In Closed-Door Talks, the U.S. and E.U. Are Excluding Covid-19 Tests, Antivirals From Patent Waiver Negotiations

The exclusion bucks the demands of global activists, who say diagnostics and therapeutics must be included in any final deal.

This post was originally published on In These Times.